Skip to content
Riskpilot
← Back to search
Sign in
Get full access
BioLogical Solutions Stockholm AB
AB
Active
Org 5594094822
Ljusnevägen 56, 128 48
Bagarmossen
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2022
1-4 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
BioLogical Solutions Stockholm AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2023
1M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
1M
2023
1M
2024
Income statement
SEK thousands
Item
2023
2024
Revenue
1 028
1 293
Staff expenses
−2
−9
EBITDA
960
1 185
Depreciation & amort.
—
—
EBIT
960
1 185
Net financials
0
1
Profit before tax
720
888
Tax
−148
−184
Net profit
572
704
Balance sheet
SEK thousands
Item
2023
2024
Total assets
903
2 020
Equity
597
1 300
Long-term debt
—
—
Short-term debt
67
181
Total debt
67
181
Financial ratios
5-year trend
EBITDA margin
91.6%
This company
15.8%
Market median
+480% vs market
2023
2024
Equity ratio
64.4%
This company
38.2%
Market median
+69% vs market
2023
2024
Return on equity
54.1%
This company
18.4%
Market median
+194% vs market
2023
2024
Net profit margin
54.4%
This company
8.1%
Market median
+572% vs market
2023
2024
Asset turnover
0.64×
This company
1.12×
Market median
-43% vs market
2023
2024
Debt / equity
0.55×
This company
0.62×
Market median
+11% vs market
2023
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-12-05 – 2023-12-31
View
PDF
More on BioLogical Solutions Stockholm AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
